Cost-effectiveness of human papillomavirus vaccination in Germany
Oliver Damm(Bielefeld University), Wolfgang Greiner(Bielefeld University), B. Ultsch(Robert Koch Institute), Yvonne Deleré(Robert Koch Institute), Mirjam Kretzschmar(Utrecht University), Andreas M. Kaufmann(Charité - Universitätsmedizin Berlin), Johannes Horn(Martin Luther University Halle-Wittenberg), Rafael Mikolajczyk(Luther University), Alexander Krämer(Bielefeld University), Ole Wichmann(Robert Koch Institute)
Cited by 32
Related Papers
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
|Quality of Life Research|2010|903
Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study
|The Lancet Public Health|2020|794
German Value Set for the EQ-5D-5L
|PharmacoEconomics|2018|618
Global Disease Burden Estimates of Respiratory Syncytial Virus–Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis
|The Journal of Infectious Diseases|2019|534